ImmunityBio, Inc. | LinkedIn (original) (raw)
About us
ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells. The activation of the innate immune system is key to the development of immunological memory. Over the last two decades, our founder and Executive Chairman Dr. Patrick Soon-Shiong has investigated mechanisms to activate the immune system to attack tumors that can otherwise evade and escape the body’s defense mechanisms. After inventing the world’s first protein nanoparticle drug, Abraxane, Dr. Soon-Shiong turned his focus to the next generation of immunotherapies. ImmunityBio was founded in 2014 to create innovative immunotherapies that address serious unmet needs in oncology and infectious diseases. "At ImmunityBio, we envision a day when we no longer fear cancer but are able to conquer it, thanks to the biological wonder that is the human immune system. Our scientists are working to develop remarkable new therapies that harness that inherent power by amplifying both branches of the immune system, attacking cancerous or infected cells today while building immunological memory for tomorrow. The goal: to reprogram the patient’s immune system and treat the host rather than just the disease." -Dr. Patrick Soon-Shiong, Executive Chairman
Industry
Biotechnology Research
Company size
501-1,000 employees
Headquarters
San Diego, CA
Type
Public Company
Specialties
Immunotherapy, Cancer, Infectious Diseases, Natural Killer, T Cell, Vaccines, Oncology, Vaccine, Fusion Proteins, Clinical Trials, Manufacturing, COVID-19, Yeast, and Cell Therapy
Locations
- Primary
3530 John Hopkins Ct
San Diego, CA 92121, US
Get directions - 9920 Jefferson Blvd
Culver City, CA 90232, US
Get directions - 430 Dudly Road
El Segundo, CA 90245, US
Get directions - 1450 Infinite Dr
Louisville, CO 80027, US
Get directions - 410 West Harrison
Seattle , WA 98119, US
Get directions - 2750 SW 145 Ave
504
Miramar, FL 33027, US
Get directions - 19 Presidential Way
104
Woburn, MA 01801, US
Get directions
Employees at ImmunityBio, Inc.
Updates
- This National Family Caregivers Month, we extend our heartfelt gratitude to the caregivers whose dedication creates a foundation of hope for patients across the world. Your compassion and resilience are vital.
- ImmunityBio is working towards a future free from fear of cancer. By tapping into the power of the immune system, we're innovating therapies that bring new hope to patients and their loved ones. View our pipeline: https://lnkd.in/dYwrAigj
- On Veterans Day, we honor the courage and sacrifice of those who have served. Their resilience inspires us to push forward in the pursuit of a healthier future. Thank you for your service.
- NMIBC's high recurrence rate is associated with diminished quality of life, significant financial burden, and greater mortality risk. ImmunityBio understands the critical need for innovative treatment options. Learn more about our studies: https://lnkd.in/gJmy4pZg
- We’re grateful to attend this year’s SITC Annual Meeting. Collaboration with other leading experts in cancer immunotherapy fuels our passion for advancing research and improving patient outcomes. #SITC24
- This Lung Cancer Awareness Month, we recognize the veterans whose sacrifices extend beyond their service. The U.S. Department of Veteran's Affairs reports nearly 8,000 veterans are faced with a lung cancer diagnosis each year, highlighting the urgent need for new treatments. Learn more about our clinical trial for non-small cell lung cancer: https://lnkd.in/gjHm-nak
- Expanding treatment options is crucial for improving outcomes for those affected by complex diseases like non-small cell lung cancer. As we observe Lung Cancer Awareness Month, we extend our heartfelt support to those impacted.
- We're grateful to join fellow urology experts at the 100th Annual Western Section AUA Meeting. It is collaboration that drives us to innovate therapies that enhance patient outcomes.
- We look forward to participating in the Bladder & Kidney Cancer Academy, where we will collaborate with passionate healthcare experts to make impactful strides in improving patient outcomes.
- ImmunityBio announced the first patients dosed in our Phase I clinical study for CAR-NK therapy for the treatment of relapsed B-Cell non-Hodgkin’s lymphoma. Learn more: https://lnkd.in/g4pvCA6c
Join now to see what you are missing
Affiliated pages
Similar pages
- Kite Pharma Biotechnology Research Santa Monica, California
- ImmPACT Bio Biotechnology Research West Hills, California
- NantKwest Biotechnology Research Culver City, CA
- Poseida Therapeutics, Inc. Biotechnology Research San Diego, California
- Allogene Therapeutics Biotechnology South San Francisco, California
- Amgen Biotechnology Research Thousand Oaks, CA
- Neogene Therapeutics Biotechnology Research Amsterdam, North Holland
- BridgeBio Biotechnology Research Palo Alto, California
- Gilead Sciences Biotechnology Research Foster City, CA
- Vertex Pharmaceuticals Biotechnology Research Boston, MA
Browse jobs
- Director jobs 1,374,979 open jobs
- Manager jobs 2,003,890 open jobs
- Medical Science Liaison jobs 2,935 open jobs
- Associate Director jobs 156,364 open jobs
- Scientist jobs 59,545 open jobs
- Engineer jobs 608,159 open jobs
- Senior jobs 1,142,468 open jobs
- Plant Manager jobs 161,328 open jobs
- Analyst jobs 760,055 open jobs
- Vice President jobs 243,153 open jobs
- Quality Engineer jobs 199,821 open jobs
- Drug Safety Associate jobs 3,631 open jobs
- Project Manager jobs 312,603 open jobs
- Director of Operations jobs 66,372 open jobs
- Senior Director of Marketing jobs 14,765 open jobs
- Clinical Trial Assistant jobs 9,020 open jobs
- Sales Director jobs 92,736 open jobs
- Head jobs 1,135,865 open jobs
- Laboratory Scientist jobs 18,681 open jobs
- Principal Scientist jobs 15,154 open jobs